AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

Similar documents
International Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT

The 2009 WHO dengue case classification: Evidence for its development and its application

An Introduction to Dengue, Zika and Chikungunya Viruses

NASRONUDIN 4/17/2013. DENVs of each type are grouped into several genotypes.

AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

Module Three About Zika Virus: What is Known and Not Known

KEY MESSAGES. There are three phases in dengue infection-febrile phase, critical phase and recovery (reabsorption) phase.

Following the bite of a mosquito infected with CHIKV, most individuals will

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS

1. Dengue An Overview. Dengue Expert Advisory Group

AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

Dengue fever. Dr Owen Tsang Princess Margaret Hospital 31 August 2018 ID forum

Fluid Management in Dengue Fever and Dengue Haemorrhagic Fever

Dengue. (Also Known as Dengue Fever, Dengue Hemorrhagic Fever, and Breakbone Fever)

Testing - Pregnant Women

Zika Virus. Centers for Disease Control and Prevention

Mercer MRC A Newsletter for and about our volunteers

Outpatient dengue management

for determining dengue severity in Thai patients

Epidemiology, clinical management and control PORNTHIP CHAICHOMPOO.

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

DENGUE. 8th Danish Paediatric Infectious Diseases Symposium 2-3 October 2015 Comwell Klarskovgaard, Korsør

10/6/2016. Outline. Zika, Dengue, and Chikungunya Viruses in the Americas Oh My! Some Mosquito-Borne Arboviruses

Travel: Chikungunya, Zika,.. New worries

Seroprevalence and Recent Trends of Dengue in a Rural Area in South India

MATERIAL AND METHODS Study objective: To study the clinical profile and predictors of mortality in children with severe dengue.

ABACAVIR HYPERSENSITIVITY REACTION

CHIKUNGUNYA VIRUS INFECTION. Cesar Ponce S. Medical Microbiologist and Parasitologist. Epidemiologist ADC Medical Microbiology Department Director

Dr. May Book-Montellano, FPPS, FPIDSP, FPSMID President Pediatric Infectious Disease Society of the Philippines

Dengue fever is the most commonly

International Journal of Health Sciences and Research ISSN:

Insect bites (dengue, Chikungunya, Zika, Tick-Borne)

Severe Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India

Chikungunya Fever: Epidemiology and Clinical Syndrome in Small Infants in Honduras June-July 2015

Clinical Information on West Nile Virus (WNV) Infection

Sharing of HA Current Protocols on Dengue Fever (DF) Ms MY KONG, SNO, HA CICO office 31 August 2018

West Nile Fever. F. Karup Pedersen 2012

Zika Virus Update for Emergency Care Providers

Dengue Vaccine. Irani Ratnam The Royal Melbourne Hospital & Peter Doherty Institute

Zika Virus: The Olympics and Beyond

General Description. Significance

Zika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology

A Study of Clinical Spectrum of Dengue Fever in A Tertiary Care

Clincal Features of Dengue

Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016

Viral hemorrhagic fevers (VHFs) By : Assis. Prof Nader Alaridah MD, PhD

An Ongoing Series. Dengue Infections. Mark Burnett, MD. Clinical

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

Myelitis= inflammation of the spinal cord

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)

A study of clinical profile of patients with Dengue fever at a tertiary care hospital

EBOLA & OTHER VIRUSES IN THE NEWS EBOLA VIRUS, CHIKUNGUNYA VIRUS, & ENTEROVIRUS D68

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

What s Lurking out there??????

ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES

Everything you ever wanted to know about Zika Virus Disease

INTRODUCTION CASE DEFINITION OF SUSPECTED DENGUE INFECTION. Review TMH Clinical Manifestations and Management of Dengue/DHF/DSS

Clinical Profile of the Dengue Infection in Children

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

RESEARCH ARTICLE STUDY OF LIVER PROFILE IN DENGUE FEVER. Surendra H S*, Adarsh E, Hema.D, Varshini.P, Sirajudheen.P, Sherin Naseer

ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, & ZIKA VIRUSES

Module Two History and Incidence

Achy, Breaky, and Sneaky. Chikungunya, Dengue, and Zika With a touch of MERS and Hemorrhagic Fevers

Clinical Management of Dengue Fever in Paediatric Patients

As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign

SERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION


This memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.

Zika Virus and Control Efforts in Arizona

KILLER BITES: Mosquito-Borne Viruses Jon Mark Hirshon, MD, MPH, PhD

Zika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona

Considerations for Risk Associated with Zika Virus (ZIKV) Background Document

Efficacy of Clinical Diagnosis of Dengue Fever in Paediatric Age Groups as Determined by WHO Case Definition 1997 in Thailand

JMSCR Vol 05 Issue 02 Page February 2017

Zika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas

Vectors and Virulence

Usa Thisyakorn and Chule Thisyakorn

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

To study the clinical profile of dengue fever and to evolve a prognostic marker based on hematological parameters for severe dengue

ZIKA VIRUS. John J. Russell MD May 27, 2016

Focus. International #57. Dengue Fever, Chikungunya and the Zika Virus. Chikungunya

TOOL FOR THE DIAGNOSIS AND CARE OF PATIENTS WITH SUSPECTED ARBOVIRAL DISEASES DENV

Measles 2015: What We Need to Know

Fluid balance in the critically ill child with dengue Too much too little? Professor Lucy Lum Universiti Malaya ASMIC Sept

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

Diseases Related to Bioterrorism

DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

MODULE V. Management of Prevalent Infections in Children Following a Disaster

Dengue: A Practical Experience of Medical Professionals in Hospital

Welcome All. Western Australia Oncology Menopause Endometriosis New Mothers

Usa Thisyakorn and Chule Thisyakorn

Adverse events following immunisation (AEFI) with 2010/2011 seasonal influenza vaccines

MODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America

Nalini Brown Nurse Manager/Travel Health Specialist London Travel Clinic

Dengue in Latin America. David Alvarado-Copenhaver

Zika virus infection Interim clinical guidance for Primary Care

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

DENGUE: Seriousness & severity prediction (2017 epidemic) Severine Page BPharm, PhD Public Health Pharmacist DASS - Service de santé publique

Transcription:

AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

HOUSEKEEPING ITEMS For educational and quality improvement purposes, this ECHO session will be recorded Project ECHO collects participation data for each ECHO session. This data allows Project ECHO to measure, analyze, and report on the ECHO movement s reach. Data is used in reports, on maps and visualizations, for research, for communications and surveys, for data quality assurance activities, and for decision-making related to new initiatives. To protect patient privacy, please do not provide any (PHI) protected health information. Please mute your microphone when not speaking. If you have video capability, please enable it. There is a chat function in Zoom that may be used to send messages to the group. For IT help, please chat to the AAP Admin and we will assist you.

TODAY S LECTURE Clues to Diagnose Clinically Dengue, Chikungunya and Zika Ana Medina, MD, FAAP Consultant to the Puerto Rico Chapter, American Academy of Pediatrics Master Trainer for the CDC Dengue Clinical Case Management Course Presented April 10, 2018

DISCLOSURES Dr. Ana L. Medina does not have any conflicts of interest to disclose.

ACKNOWLEDGMENTS Centers for Disease Control and Prevention (CDC) Puerto Rico Branch World Health Organization Pan American Health Organization Clinicians for the Dengue Control Research Programme (DENCO) Dr Lucy Lum (University of Malaysia) This project is supported by the Maternal and Child Health Bureau, Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U43MC09134

OBJECTIVE Understand the similarities and differences in the clinical manifestations of dengue, chikungunya and zika

DENGUE Dengue is a systemic and dynamic disease Its clinical manifestations are diverse, and range from an asymptomatic or mild viral illness, to a more severe disease Its onset is ABRUPT 3 Phases: Febrile Phase (2-7 days) Critical Phase (fever defervescence) (vascular leakage) Recovery Phase (Resorption)

PROBABLE DENGUE Live in/travel to dengue endemic area and fever with two of the following (CDC 2009): Nausea and vomiting Rash Leucopenia Positive tourniquet test Aches and pains (headache, retro orbital eye pain, myalgias, arthralgias) Warning signs

DENGUE WARNING SIGNS: PLASMA LEAKAGE Usually when temperature drops <38 C Restlessness; Lethargy Mucosal bleed Persistent vomiting Severe abdominal pain or tenderness Liver enlargement >2cm Clinical fluid accumulation(ascites, pleural, pericardial effusions) Laboratory increase in Hct concurrent with rapid decrease in platelets HOSPITALIZATION NEEDED! Source: CDC, 2009

DENGUE WARNING SIGNS In 2017, WHO/PAHO Dengue Classification: POSTURAL HYPOTENSION ADDED AS A NEW WARNING SIGN!!

As you can see in new Dengue classification, focus is not platelet count. Focus is on severe manifestations. The terms Dengue, DHF and DSS are substituted for Dengue and Severe Dengue

DENGUE: BASIC IMPORTANT FACTS Increased vascular permeability is the most important feature that differentiates Dengue from Severe Dengue This excessive capillary plasma leakage leads to dehydration and hypovolemic shock Plasma leakage can be mild to severe; insidious or abrupt and fluid goes to body cavities (pleural, abdominal) Severe hemorrhage is unusual and usually occurs only after prolonged hypovolemic shock and acidosis

WARNING SIGNS MOST ASSOCIATED WITH SEVERE DENGUE Severe abdominal pain Lethargy Mucosal bleed

Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch PLASMA LEAKAGE

SEVERE DENGUE Evidence of pleural effusion and ascites Photos: Dengue Clinical Case Management Course, CDC Puerto Rico Branch Suchitra Nimmannittya

With sudden onset of fever: Flushing or erythema of face, neck and chest for 1 to 2 days. May have injected pharynx and red lips. Mosquito bite Critical Phase Convalescent Phase Incubation Febrile Phase Viremic Afebrile Not viremic -2 0 2 4 6 8 10 12 * Typically uncomplicated DHF/DSS lasts for 10 to 12 days Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch

Days 2 to 6: Macular or maculopapular truncal rash that spreads to face and extremities. Mosquito bite Critical Phase Convalescent Phase Incubation Febrile Phase Viremic Afebrile Not viremic -2 0 2 4 6 8 10 12 * Typically uncomplicated DHF/DSS lasts for 10 to 12 days Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch

Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch DENGUE RASHES

DENGUE H. Laferl TMID 2006 Islands of white in the sea of red convalescent rash. J Pediatrics 1997; 131(4): 516-524 Dengue Clinical Case Management Course, CDC Puerto Rico Branch

POSITIVE TOURNIQUET TEST Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch

CHIKUNGUNYA Alphavirus The majority of patients with chikungunya become symptomatic (~90%) On the contrary, the majority of patients infected with dengue or zika have asymptomatic or subclinical illness

Abrupt onset fever (typically >39 C ) CHIKUNGUNYA Polyarthralgia/arthritis: usually bilateral and symmetric and can be severe and debilitating Small and distal joints: knees, elbows,ankles, feet, wrists, hands affected frequently Headache Eye pain Myalgias Conjunctivitis Rash: morbilliform maculopapular frequent Nausea and vomit Persistent joint symptoms for months to years reported

Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch CHIKUNGUNYA

Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch CHIKUNGUNYA

Photo: Dengue Clinical Case Management Course, CDC Puerto Rico Branch CHIKUNGUNYA

Photo: Property of Dr. Ana Medina CHIKUNGUNYA RASH

ZIKA VIRUS: SYMPTOMS OF INFECTION Most people infected with Zika virus do not experience any symptoms About 1 in 5 people will become sick, usually with a mild illness. Common symptoms include: Abrupt onset Mild fever(<39 C) Skin rash/pruritis Arthralgias Conjunctivitis Nausea, vomits, diarrhea Fatalities are rare Source: https://www.bcm.edu/departments/molecular-virology-andmicrobiology/emerging-infections-and-biodefense/zika

Photo: Property of Dr. Ana Medina ZIKA VIRUS

Photo: Property of Dr. Ana Medina ZIKA VIRUS

Photo: Property of Dr. Ana Medina RETROAURICULAR NODE IN ZIKA

Photo: Property of Dr. Ana Medina ZIKA IN YOUNG CHILD

ZIKA IN YOUNG CHILD Discreet maculo papular facial rash Photo: Property of Dr. Ana Medina

ZIKA Fine maculo papular erythematous rash Usually cephalad to caudal Photo: Property of Dr. Ana Medina

DENGUE, CHIKUNGUNYA, ZIKA Dengue and Chikungunya are high viremic viruses, thus the high fevers and marked general malaise, and body aches Zika virus is a low viremic virus, thus low fevers and mild constitutional symptoms In Zika, nevertheless, the affected fetus seems to have a chronic viremia

SIMILARITIES BETWEEN DENGUE, CHIKUNGUNYA AND ZIKA Abrupt onset fever/chills (lower fever in Zika and less chills in Zika) Headache General malaise Nausea/ vomits/ diarrhea Rash Conjunctivitis Arthralgias/ Myalgias CNS autoimmune disorders Hepatitis A aegypti vector Similar endemic area

CLINICAL CLUES FOR DENGUE INFECTION Rash Early facial rash; sometimes is the only rash reported Pruritic rash in late or recovery/convalescent phase Arthralgias / Myalgias Headache & retro orbital pain (EOM myalgias) Sudden fever and lumbar pain or abrupt lumbar pain followed several hours later by fever*** Positive Tourniquet Test Leukopenia Warning signs, especially ABDOMINAL PAIN Pt feels weak and dizzy when getting up Pleural effusions in Chest X-ray after fever defervescence Shock after fever goes away After fever defervescence, bradycardia and subnormal temperature seen in most patients*** Other family members with similar- non respiratory illness Endemic area

CLINICAL CLUES FOR CHIKUNGUNYA INFECTION High fever (sometimes 105-106 F in patients who never had such high fevers in previous illnesses) Polyarthralgias, especially small joints hands, wrists, feet, ankles Debilitating joint pains; patients tend to fall or simply do not want to get up or cannot walk Lymphopenia / Leukopenia Morbilliform rash Other family members with similar non-respiratory illness Endemic area

CLINICAL CLUES FOR ZIKA INFECTION Mild general malaise Fever usually <39 C = 102.2 F Arthralgias, myalgias (mild), including periarticular edema (esp hands), marked edema, but mild discomfort! Rash OR PRURITIS early in illness or as the only manifestation!! Rash over cheeks Retroauricular node(s) Conjunctivitis Guillain-Barré Other family members with similar mild non-respiratory illness Endemic area

MOST FREQUENT REASON TO CONSULT MD OR ACUTE CLINIC/ER Dengue Chikungunya Zika Fever & Myalgias Fever & Joint Pain Rash / Pruritus

Source: Tool for the Diagnosis and Care of Patients with Suspected Arboviral Diseases, 2017. http://iris.paho.org/xmlui/ha ndle/123456789/33895

QUESTIONS? THANK YOU GRACIAS